Dr. Mcginnis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4867 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-783-4011
Education & Training
- UPMC Medical EducationResidency, Physical Medicine and Rehabilitation, 2014 - 2018
- Children's Hospital of PhiladelphiaResidency, Epilepsy, 2015 - 2016
- University of Pennsylvania Health SystemResidency, Neurology, 2012 - 2015
- Children's Hospital of PhiladelphiaResidency, Child Neurology, 2012 - 2015
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2010 - 2012
- State University of New York Downstate Medical Center College of MedicineClass of 2010
Certifications & Licensure
- CA State Medical License 2016 - 2025
- OR State Medical License 2017 - 2025
- WA State Medical License 2017 - 2025
- PA State Medical License 2010 - 2016
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- 118 citationsKCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients.John Millichap, Kristen Park, Tammy Tsuchida, Bruria Ben-Zeev, Lionel Carmant
Neurology. Genetics. 2016-10-01 - 31 citationsLacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.Emily L. McGinnis, Sudha Kilaru Kessler
Epilepsia. 2016-09-01 - 1 citationsEducation Research: Quality and Validity Evidence for a National In-Training Examination for Epilepsy Fellows.Jeremy Moeller, Ernesto Gonzalez-Giraldo, France W Fung, Emily L Johnson, Ammar Kheder
Neurology. Education. 2023-12-22
Press Mentions
- Taysha Gene Therapies : Builds Experienced Executive Leadership Team to Advance Pipeline of Gene Therapies for Monogenic CNS Disease in Both Rare and Large Patient PopulationsAugust 31st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: